Oncology is a dedicated Therapeutic Area and key strategic growth pillar under Pfizer Germany’s Strategic Roadmap 2030, with an ambition to deliver eight cancer breakthroughs by 2030 across solid tumors and hematology. Medical Affairs serves as the scientific engine of the Oncology organization — translating pioneering science into meaningful impact for patients, HCPs, and the broader healthcare ecosystem.

This visible leadership role has a forward-looking mandate focused on pre-launch and emerging assets — including targeted therapies, ADCs, and bispecifics — building the medical foundation of disease-area science, data strategy, and site network that enables fast, high-quality launches, reflected in strong scientific partnerships, robust early evidence, and effective collaboration with GSSO and the International Medical organization. The precise indication scope will be defined together with the Oncology leadership team.

Strategy & Vision

• Define the multi-year Medical Affairs strategy for the emerging Oncology pipeline in Germany, aligned with the Strategic Roadmap 2030 and the global Oncology pipeline strategy, while maintaining clear medical independence and compliance boundaries.

• Anticipate the evolving scientific and healthcare-system landscape and establish Pipeline Medical Affairs as an early, trusted scientific partner for emerging mechanisms and indications.

Scientific Collaborations & Ecosystem Leadership

• Build trusted early scientific partnerships with KOLs, academic centers, cooperative study groups, scientific societies, and clinical research networks ahead of launch, across HCPs, patient organizations, payers, and policy makers.

• Act as the medical single front door for scientific collaborations and investigator-sponsored research proposals for pipeline assets, within applicable compliance standards and the non-promotional boundary.

Scientific Leadership, Evidence Generation & Clinical Studies

• Own the Pipeline Medical Plan and integrated early-evidence strategy, leading early evidence generation — real-world evidence, epidemiology, registries, investigator-sponsored research, medical education, and publications — to characterize emerging disease areas and close anticipated evidence gaps.

• Collaborate with the International Medical organization, global medical, clinical development, HEOR, access, and regulatory colleagues to shape data strategy and ensure local insights inform broader planning across markets.

• Closely collaborate with GSSO on clinical study execution in Germany, including Country Outreach, study-site identification, and driving speedy site recruitment for pipeline studies.

• Utilize advanced analytics and AI-enabled insight synthesis to shape data strategy, accelerate scientific readiness, and support healthcare-system decision-making.

Market Access Readiness (Medical/Scientific Support)

• Provide early medical/scientific support to shape future benefit dossiers and reimbursement evidence, anticipating added-benefit requirements and steering data generation early to close gaps ahead of launch, in partnership with Access & Value.

Launch Preparation & Medical Readiness

• Lead Medical launch readiness for the emerging Oncology pipeline, ensuring scientific, capability, and site-network readiness so assets transition smoothly from pipeline into launch and in-line management.

• Drive differentiation through early evidence generation, medical storytelling, and scientific engagement.

Leadership & Talent

• Build, develop, and inspire a high-performing Pipeline Medical team, fostering a culture of accountability, inclusion, innovation, and collaboration.

• Attract, retain, and grow top scientific talent through succession planning and development, dedicating a substantial share of leadership time to coaching, feedback, and clear prioritization.

• Drive alignment within the Medical Leadership Team to share capabilities and drive joint success across therapeutic areas.

AI, Innovation & Medical Transformation

• Champion responsible, compliant use of AI — with human oversight of AI-generated outputs — and build AI fluency and sound scientific judgment across the team.

• Simplify ways of working and eliminate low-value activities to maximize time for scientific exchange and patient impact.

Compliance & Scientific Integrity

• Ensure compliance with all legal, regulatory, and Pfizer policy requirements — upholding the non-promotional boundary, scientific integrity, pharmacovigilance, medical governance, and balanced scientific communication.

What You'll Bring

Basic Qualifications

• Significant Medical Affairs leadership experience in pharma/biotech, with experience in Oncology/hematology-oncology strongly preferred

• Medical degree, pharmacy degree, PhD, or equivalent advanced scientific qualification required

• Proven track record in early evidence generation, scientific collaborations, scientific communication, and stakeholder engagement

• People-management experience, including direct team leadership, preferred

• Fluent business and medical English; German (native or C1-level) mandatory

Scientific & Technical Expertise

• Strong scientific credibility and Medical Affairs expertise, with the ability to engage external experts confidently, and a good understanding of clinical research, real-world evidence, medical governance, healthcare systems, and regulatory requirements

• Comfort with digital and AI-enabled ways of working, including critical review of AI-generated outputs in a regulated setting

Preferred Qualifications

• Experience collaborating with clinical operations or GSSO on study-site identification, Country Outreach, or clinical study recruitment

• Experience in pre-launch medical strategy, scientific collaborations, and cooperative study groups

• Demonstrated success leading complex matrix organizations and high-performing teams through transformation

• Strategic mindset with the ability to turn priorities into clear, disciplined execution, and to lead teams through ambiguity, complexity, and change

• Strong partnership, influencing, and communication skills with internal and external stakeholders

• People leader with experience in coaching, talent development, and team engagement

• Sound judgement and accountability in scientific, compliant, and patient-focused decision-making

„Breakthroughs that change patients’ lives“ - Unser klares Unternehmensziel ist es, Durchbrüche zu erreichen, die das Leben von PatienInnen verändern. Sie sind der Sinn unseres Tuns. Wenn Sie Teil dieser Vision sein wollen und die gleiche Leidenschaft teilen, ist Pfizer der ideale Ort, um eine Karriere zu beginnen oder um eine erfolgreich fortzusetzen.  

Überzeugt? 

Dann freuen wir uns über Ihre Online-Bewerbung mit vollständigen und aussagekräftigen Unterlagen (Anschreiben, Lebenslauf und Dateien wie Zeugnisse u.ä.  können Sie unter „Meine Berufserfahrung" unter Ihrem Lebenslauf hinzufügen und hochladen). 

Bitte beachten Sie, dass wir aus Datenschutzgründen ausschließlich Bewerbungen über unsere Plattform annehmen können. 

Pfizer garantiert Chancengleichheit während des gesamten Bewerbungsprozesses sowie die Einhaltung der lokalen Gesetzgebungen in den jeweiligen Ländern, in denen Pfizer agiert. Pfizer schließt jegliche diskriminierende Faktoren aus, die u. a. das Geschlecht und Alter, die ethnische Zugehörigkeit, Religion oder Weltanschauung, sexuelle Orientierung oder Behinderung betreffen. 

Inklusion von Menschen mit Behinderungen  

Unser Anliegen ist es, allen Mitarbeitenden zu ermöglichen, dass Sie ihre Fähigkeiten und Kenntnisse voll einbringen und weiterentwickeln können. Wir sind stolz darauf, ein inklusiver Arbeitgeber zu sein, indem wir allen Bewerber:innen gleiche Chancen bieten. Wir ermutigen Sie, sich von Ihrer besten Seite zu zeigen, mit dem Wissen und dem Vertrauen, dass wir alle angemessenen Anpassungen vornehmen werden, um Ihre Bewerbung und Ihre zukünftige Karriere zu unterstützen. Ihre Reise mit Pfizer beginnt hier!